US Cancer Test Market Growth: Liquid Biopsy Takes Center Stage
The US cancer test market is advancing as greater emphasis is placed on early detection, accurate diagnosis, and personalized cancer care. Increasing adoption of molecular diagnostics, biomarker testing, liquid biopsy, and advanced screening technologies is helping clinicians identify cancer and characterize disease more precisely. Continued innovation in diagnostic platforms and growing...
0 Commenti 0 condivisioni 182 Views 0 Anteprima